The weekly litigation news digest is live. Subscribe now

IP Verse

Pharmaceutical Formulations - EP4233846

The patent EP4233846 was granted to Gilead Sciences on Dec 4, 2024. The application was originally filed on Jun 29, 2016 under application number EP23162978A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4233846

GILEAD SCIENCES
Application Number
EP23162978A
Filing Date
Jun 29, 2016
Status
Granted And Under Opposition
Nov 1, 2024
Publication Date
Dec 4, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ELKINGTON AND FIFESep 4, 2025ELKINGTON AND FIFEADMISSIBLE
EIPSep 3, 2025EIPADMISSIBLE
HAMM & WITTKOPPSep 2, 2025HAMM & WITTKOPPADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO0208241
DESCRIPTIONWO03016306
DESCRIPTIONWO2013025788
OPPOSITIONWO2004064846
OPPOSITIONWO2006135932
OPPOSITIONWO2013025788
OPPOSITIONWO2013116720
OTHERWO0208241
OTHERWO2004064846
OTHERWO2006135932
OTHERWO2013025788
SEARCHWO2013116720
SEARCHWO2015022351
SEARCHWO2015196116

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents